Cargando…

INTRAVITREAL RANIBIZUMAB TREATMENT FOR ADVANCED FAMILIAL EXUDATIVE VITREORETINOPATHY WITH HIGH VASCULAR ACTIVITY

PURPOSE: To determine the efficacy of intravitreal ranibizumab (IVR) treatment for advanced familial exudative vitreoretinopathy with high vascular activity. METHODS: The retrospective interventional case series included 28 eyes (20 patients) that had IVR in combination or not with other treatment,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lyu, Jiao, Zhang, Qi, Xu, Yu, Zhang, Xiang, Fei, Ping, Zhao, Peiquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Retina 2021
Materias:	Original Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384247/ https://www.ncbi.nlm.nih.gov/pubmed/34432746 http://dx.doi.org/10.1097/IAE.0000000000003122

Ejemplares similares

Prenatal diagnosis of familial exudative vitreoretinopathy and Norrie disease
por: Liu, Jingjing, et al.
Publicado: (2018)

Identification of two novel LRP5 mutations in families with familial exudative vitreoretinopathy
por: Fei, Ping, et al.
Publicado: (2014)

Identification of novel KIF11 mutations in patients with familial exudative vitreoretinopathy and a phenotypic analysis
por: Li, Jia-Kai, et al.
Publicado: (2016)

Familial Exudative Vitreoretinopathy
por: Sızmaz, Selçuk, et al.
Publicado: (2015)

Novel mutations in the TSPAN12 gene in Chinese patients with familial exudative vitreoretinopathy
por: Xu, Yu, et al.
Publicado: (2014)

Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity
por: Chen, Xuting, et al.
Publicado: (2019)

Variable reduction in Norrin signaling activity caused by novel mutations in FZD4 identified in patients with familial exudative vitreoretinopathy
por: Tian, Tian, et al.
Publicado: (2019)

Identification and functional analysis of novel FZD4 mutations in Han Chinese with familial exudative vitreoretinopathy
por: Fei, Ping, et al.
Publicado: (2015)

Foveal Exudative Macroaneurysm Treated with Intravitreal Ranibizumab
por: Menezes, Carlos, et al.
Publicado: (2015)

Identification of a novel mutation in KIF11 with functional analysis in a cohort of 516 familial patients with exudative vitreoretinopathy
por: Wang, Kezhou, et al.
Publicado: (2021)

Asymmetric presentations of familial exudative vitreoretinopathy
por: Natung, Tanie, et al.
Publicado: (2013)

Five novel copy number variations detected in patients with familial exudative vitreoretinopathy
por: Luo, Jia, et al.
Publicado: (2021)

Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab
por: Takayama, Kei, et al.
Publicado: (2012)

CTNND1 variants cause familial exudative vitreoretinopathy through the Wnt/cadherin axis
por: Yang, Mu, et al.
Publicado: (2022)

One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration
por: Nakamura, Tomoko, et al.
Publicado: (2012)

AFLIBERCEPT AFTER RANIBIZUMAB INTRAVITREAL INJECTIONS IN EXUDATIVE AGE–RELATED MACULAR DEGENERATION: The ARI2 Study
por: Blanco-Garavito, Rocio, et al.
Publicado: (2018)

Dry-Lensectomy Assisted Lensectomy in the Management for End-Stage Familial Exudative Vitreoretinopathy Complicated With Anterior Segment Abnormalities
por: Peng, Jie, et al.
Publicado: (2022)

Familial exudative vitreoretinopathy presentation as persistent fetal vasculature
por: Kartchner, Jeffrey Z., et al.
Publicado: (2017)

Posterior keratoconus in a patient with familial exudative vitreoretinopathy
por: Agarwal, Pulak, et al.
Publicado: (2020)

Familial exudative vitreoretinopathy associated with retinal astrocytic hamartoma
por: Fan, Jason, et al.
Publicado: (2022)

Unilateral Familial Exudative Vitreoretinopathy: Clinical Profile and Pathology
por: Boal, Nina S., et al.
Publicado: (2021)

Mutation spectrum in a cohort with familial exudative vitreoretinopathy
por: Qu, Ning, et al.
Publicado: (2022)

Viscodelamination of Localized Retrolental Plaques During Lens-Sparing Vitrectomy in Eyes With Pediatric Tractional Vitreoretinopathy
por: Lyu, Jiao, et al.
Publicado: (2023)

Ganglion Cell Complex Evaluation in Exudative Age-Related Macular Degeneration after Repeated Intravitreal Injections of Ranibizumab
por: Perdicchi, Andrea, et al.
Publicado: (2015)

Quantitative Analysis of Vascular Abnormalities in Full-Term Infants With Mild Familial Exudative Vitreoretinopathy
por: Li, Peng, et al.
Publicado: (2023)

Refractive Status and Biometric Characteristics of Children With Familial Exudative Vitreoretinopathy
por: Hu, Yarou, et al.
Publicado: (2023)

Asymmetric Outcomes of Type 1 Retinopathy of Prematurity after Bilateral Intravitreal Ranibizumab Treatment
por: Huang, Qiujing, et al.
Publicado: (2017)

Clinical characteristics and mutation spectrum in 33 Chinese families with familial exudative vitreoretinopathy
por: Mao, Jianbo, et al.
Publicado: (2022)

Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage
por: Xu, Yu, et al.
Publicado: (2016)

Whole-Gene Deletions of FZD4 Cause Familial Exudative Vitreoretinopathy
por: Huang, Li, et al.
Publicado: (2021)

Genetic and clinical characteristics of ZNF408-related familial exudative vitreoretinopathy
por: Tao, Xueying, et al.
Publicado: (2023)

Adams Oliver syndrome: A mimicker of familial exudative vitreoretinopathy
por: Alsulaiman, Alwaleed M., et al.
Publicado: (2020)

Ocular Features and Mutation Spectrum of Patients With Familial Exudative Vitreoretinopathy
por: Tao, Tianchang, et al.
Publicado: (2021)

Commentary: Familial exudative vitreoretinopathy-The masquerade in pediatric retinal disorders
por: Sen, Parveen, et al.
Publicado: (2022)

Familial exudative vitreoretinopathy complicated with macular hole retinal detachment
por: Singh, Priyanka, et al.
Publicado: (2023)

Vascular features around the optic disc in familial exudative vitreoretinopathy: findings and their relationship to disease severity
por: Liu, Shuai, et al.
Publicado: (2023)

Management of retinal artery macroaneurysm exudation in Wyburn-Mason syndrome with intravitreal ranibizumab
por: Naik, Anmol U, et al.
Publicado: (2019)

Experience with Intravitreal Ranibizumab as an Adjunct to Ablation Therapy in Eyes with Exudative Coats’ Disease
por: Nowara, Mohamed, et al.
Publicado: (2021)

Intravitreal Aflibercept Outcomes in Patients with Persistent Macular Exudate Previously Treated with Bevacizumab and/or Ranibizumab for Neovascular Age-Related Macular Degeneration
por: Griffin, David R., et al.
Publicado: (2014)

Novel TSPAN12 mutations in patients with familial exudative vitreoretinopathy and their associated phenotypes
por: Yang, Huiqin, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vb26lbulrs43p7ed1gcmtqaeus